Systemic Sclerosis-associated Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Systemic Sclerosis-associated Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH [Phase 2]
Phase 2 clinical trial update on the efficacy and safety of riociguat for incipient pulmonary vascular disease as an early indicator for pul…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Cardiac Assessment by PV Loop in IPAH and Scleroderma PAH
Johns Hopkins University conducted a clinical trial using PV loop cardiac assessment in patients with idiopathic pulmonary arterial hyperten…
-
CLINICAL_TRIALS trial_result · 2020-08-21Clinical Trial Update: Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) [Phase 2]
Phase 2 trial evaluating rituximab for systemic sclerosis-associated pulmonary arterial hypertension has completed; results posted in 2020.